Market InstituteMarket Institute
  • About
    • Who We Are
  • Research & Commentary
    • Papers
  • Events
  • Issues
  • Projects
    • International Overreach: When Global Standards Become U.S. Policy
    • Alzheimer’s
    • Letters
    • Political Cartoons

Articles

Articles

Congress Doing What It Should Do – Defending Innovators

The Market Institute President Charles Sauer has a new article in Real Clear Markets on a bill recently introduced in Congress called the PREVAIL Act. If passed, it will help level the playing field for inventors, most notably by attempting to fix the Patent Trial and Appeals Board. He writes: Read more…

By admin, 3 years3 years ago
Articles

Kanter and Khan Antitrust Crusade Riddled with Conflicts of Interest

The Market Institute President Charles Sauer has a new article in Real Clear Policy spotlighting the serious issues at the Federal Trade Commission, and specifically Jonathan Kanter, assistant attorney general for the Department of Justice Antitrust Division. “Two years ago, President Joe Biden laid out his administration’s antitrust agenda, a plan Read more…

By admin, 3 years3 years ago
Articles

Hater of All Things Big Lina Khan Shifts Her Gaze to Soft Drinks

The Market Institute President Charles Sauer as a new article in Real Clear Markets on a report the Federal Trade Commission has contacted large retailers regarding the pricing of soda drinks. He writes: “The Cola Wars 2.0 have begun, but this time they are on the same side. Coke and Read more…

By admin, 3 years3 years ago
Articles

Dear Lina Khan, If Collective Bargaining Makes Sense, So Do Mergers

The Market Institute Senior Fellow Norm Singleton has a new article in Real Clear Markets looking at the irony of the Federal Trade Commission and Chairwoman Lina Khan for not targeting one type of organization for antitrust litigation: labor unions. “Federal Trade Commission Chair Lina Khan is so eager to drag businesses Read more…

By admin, 3 years3 years ago
Articles

Are the British Doing Lina Khan’s Dirty Work?

The Market Institute Senior Fellow Norm Singleton has a new article in Real Clear Markets on the Microsoft-Activision merger and attempts by the Federal Trade Commission to stop it. He writes: “Federal Trade Commission Chair Lina Khan is one of the most controversial of all of President Biden’s appointments. This is in Read more…

By admin, 3 years3 years ago
Articles

Lina Khan’s ‘Underfunded’ FTC Takes Its Act To Europe

The Market Institute President Charles Sauer has a new article in Real Clear Markets highlighting the Federal Trade Commission’s cooperation with European regulators. He writes: “At a recent hearing of the House Committee on Energy and Commerce’s Subcommittee on Innovation, Data, and Commerce, Federal Trade Commission (FTC) Chair Lina Khan Read more…

By admin, 3 years3 years ago
Articles

Only Amazon Knows That It’s Not a ‘Monopoly’

Senior Fellow at The Market Institute John Tamny has a new article in Real Clear Markets highlighting the nature of Amazon’s business – not raising prices, increasing customer satisfaction, and increasing profitability. He writes: “It has “upended its vast logistics network to reduce how far packages travel across the U.S. Read more…

By admin, 3 years3 years ago
Articles

The Drumline of Regulation Marches On and Marches In

The Market Institute President Charles Sauer has a new article in Real Clear Policy looking at the problems with price setting drug prices. There are attempts by the Biden Administration to use “March In” rights to implement price controls – even at the expense of future innovation. He writes: “In Read more…

By admin, 3 years3 years ago
Articles

Lina Khan Disdains ‘Big Tech’ and the First Amendment

The Market Institute Senior Fellow Norm Singleton has a new piece in Real Clear Markets looks at FTC Chair Lina Khan’s disregard for free speech despite her reverence for former Supreme Court Justice Louis Brandeis, who was a champion of free speech. He writes: “Federal Trade Commissioner Lina Khan and Read more…

By admin, 3 years3 years ago
Articles

Republican Debt Limit Bill Deserves Biden’s Fair Engagement

The Market Institute President Charles Sauer has a new article in the Washington Examiner’s Restoring America series on the quickly approaching “X-Day” for a United States government default. He argues for a resolution to this impending crisis with both sides playing a crucial role. President Joe Biden and the Democratic Read more…

By admin, 3 years3 years ago

Posts pagination

Previous 1 … 22 23 24 … 32 Next
Recent Articles
  • A Government That’s Trying to Please You Will Make You Miserable October 16, 2026
  • How I Stopped Worrying, and Learned to Love Data Centers October 15, 2026
  • Charles Sauer: Government Policy Is Fueling Hospital Consolidation October 13, 2026
  • Patients First Act: Protecting Choice and Taxpayers October 9, 2026
  • Most Favored Nation Price Controls Disfavor Patients October 5, 2026
Recent Papers
  • The Trouble with Tariffs
  • The $135 Billion Lie: How Upcoding Is Draining Medicare and Medicaid
  • Why Does the Government Pay More for the Same Care?
  • The Practical, Constitutional, and Moral Case Against Social Media Regulation “For the Children”
  • Free Markets Under Attack from the Left and Right

Loading

By adding your phone number, you opt in to receive text messages

Facebook
Twitter
YouTube

The Market Institute Verified account Follow

We promote free market public policies. We get government out of the way.

MarketInstitute
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Businesses should be able to succeed or fail based on how they perform, not how much the government has invested in them. A free market means letting businesses compete on their own, not having the government take a bigger seat at the table.

Stephen Moore @StephenMoore

Memo to the Trump administration: Stop buying companies.

A government $40 trillion in debt should be SELLING assets, not buying ownership stakes in 36 companies.

We thought government control of the means of production was what we were fighting against.

Reply on Twitter 2113667268819182035 Retweet on Twitter 2113667268819182035 Like on Twitter 2113667268819182035 X 2113667268819182035
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

The goal should be simple: protect national security without blocking promising medicines from reaching American patients.

Broad biotech restrictions risk doing exactly that.

Axios @axios

Trump administration proposes new curbs on China biotech deals https://www.axios.com/2026/10/23/trump-china-biotech-restrictions?utm_campaign=mrf-utm_source=x&utm_medium=organic_social&utm_campaign=editorial&utm_source=twitter&utm_medium=social&mrfcid=202610236ad04fc1adeaa64e72130b68

Reply on Twitter 2113627990798049521 Retweet on Twitter 2113627990798049521 Like on Twitter 2113627990798049521 X 2113627990798049521
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Protecting inventors is a founding American principle. Strong patent rights give innovators the incentive to build what comes next.

As @newtgingrich puts it:

“We want to encourage inventors. We want to give them legal protection so they have an incentive.”

Reply on Twitter 2113626326032928990 Retweet on Twitter 2113626326032928990 Like on Twitter 2113626326032928990 X 2113626326032928990

  • About
  • Research & Commentary
  • Events
  • Issues
  • Projects